Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia

BACKGROUND: The ongoing epidemic of multidrug-resistant tuberculosis (MDR-TB) in Georgia highlights the need for more effective control strategies. A new regimen to treat MDR-TB that includes pyrazinamide (PZA) is currently being evaluated and PZA resistance status will largely influence the success...

Descripción completa

Detalles Bibliográficos
Autores principales: Sengstake, Sarah, Bergval, Indra L, Schuitema, Anja R, de Beer, Jessica L, Phelan, Jody, de Zwaan, Rina, Clark, Taane G, van Soolingen, Dick, Anthony, Richard M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506614/
https://www.ncbi.nlm.nih.gov/pubmed/28697808
http://dx.doi.org/10.1186/s12879-017-2594-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506614/
https://www.ncbi.nlm.nih.gov/pubmed/28697808
http://dx.doi.org/10.1186/s12879-017-2594-3

Ejemplares similares